Species difference exists in the effects of 1α,25(OH)2D3 and its analogue 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 (2MD) on osteoblastic cells

Haussler, 1998, The nuclear vitamin D receptor: biological and molecular regulatory properties revealed, J. Bone Miner Res., 13, 325, 10.1359/jbmr.1998.13.3.325 Jones, 1998, Current understanding of the molecular actions of vitamin D, Physiol. Rev., 78, 1193, 10.1152/physrev.1998.78.4.1193 Gurlek, 2001, Regulation of osteoblast growth by interactions between transforming growth factor-beta and 1alpha,25-dihydroxyvitamin D3, Crit. Rev. Eukaryot. Gene Expr., 11, 299 van Driel, 2006, Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization, J. Cell. Biochem., 99, 922, 10.1002/jcb.20875 Ecarot, 1999, 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast, Endocrinology, 140, 1192, 10.1210/en.140.3.1192 Berger, 2004, Differentiation of cultured mice bone marrow into osteoblast-like cells results in acquisition of sex-specific responsiveness to gonadal steroids, J. Endocrinol. Invest., 27, 622, 10.1007/BF03347493 Sicinski, 1998, New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues, J. Med. Chem., 41, 4662, 10.1021/jm9802618 Shevde, 2002, A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation, Proc. Natl. Acad. Sci. U.S.A., 99, 13487, 10.1073/pnas.202471299 Plum, 2006, 2MD, a new anabolic agent for osteoporosis treatment, Osteoporos Int., 17, 704, 10.1007/s00198-005-0036-3 Rodan, 1997, The missing bone, Cell, 89, 677, 10.1016/S0092-8674(00)80249-4 Jilka, 1998, Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines, J. Bone Miner Res., 13, 793, 10.1359/jbmr.1998.13.5.793 Jilka, 1999, Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone, J. Clin. Invest., 104, 439, 10.1172/JCI6610 Suda, 2003, Vitamin D and bone, J. Cell. Biochem., 88, 259, 10.1002/jcb.10331 Erben, 1997, Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow, Endocrinology, 138, 4629, 10.1210/en.138.11.4629 Lindgren, 1983, Oral 1,25(OH)2D3: an effective prophylactic treatment for glucocorticoid osteopenia in rats, Calcif. Tissue Int., 35, 107, 10.1007/BF02405014 Lindgren, 1983, Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3, Clin. Orthop. Relat. Res., 181, 264, 10.1097/00003086-198312000-00041 Lindgren, 1982, Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats, Calcif. Tissue Int., 34, 253, 10.1007/BF02411246 Lindgren, 1981, Effects of 1,24-dihydroxyvitamin D3 and calcitonin on fracture healing in adult rats, Clin. Orthop. Relat. Res., 160, 304, 10.1097/00003086-198110000-00043 Erben, 1998, Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone, Endocrinology, 139, 4319, 10.1210/en.139.10.4319 Yoshizawa, 1997, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning, Nat. Genet., 16, 391, 10.1038/ng0897-391 Amling, 1999, Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses, Endocrinology, 140, 4982, 10.1210/en.140.11.4982 Tanaka, 2004, Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition, J. Steroid. Biochem. Mol. Biol., 89–90, 343, 10.1016/j.jsbmb.2004.03.021 Lindgren, 1984, Effects of 1,25(OH)2D3 on bone tissue in the rabbit: studies on fracture healing, disuse osteoporosis, and prednisone osteoporosis, Calcif. Tissue Int., 36, 591, 10.1007/BF02405372 Lian, 1997, Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression, Endocrinology, 138, 2117, 10.1210/en.138.5.2117 Tilyard, 1992, Treatment of postmenopausal osteoporosis with calcitriol or calcium, N. Engl. J. Med., 326, 357, 10.1056/NEJM199202063260601 Morales, 2004, Effects of 1alpha,25-dihydroxyvitamin D3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells, Endocrinology, 145, 87, 10.1210/en.2003-0718 Caswell, 1991, Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects, Crit. Rev. Clin. Lab. Sci., 28, 175, 10.3109/10408369109106862